Collegium Pharmaceutical Inc reports results for the quarter ended December 31 - Earnings Summary

Collegium Pharmaceutical

27/02/2025 22:01

Collegium Pharmaceutical Inc COLL.OQ reported quarterly adjusted earnings of $1.77​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 82 cents.  The mean expectation of five analysts for the quarter was for earnings of $1.54 per share. Wall Street expected results to range from $1.49  to $1.63 per share.

Revenue rose 21.5% to $181.95 million from a year ago; analysts expected $179.79 million.

Collegium Pharmaceutical Inc's reported EPS for the quarter was 36 cents​.

The company reported quarterly net income of $12.54 million.

Collegium Pharmaceutical Inc shares had fallen by 1.0% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 2.2% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Collegium Pharmaceutical Inc is $42.00

This summary was machine generated from LSEG data February 27 at 10:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Dec. 31 2024
1.54
1.77
Beat
Sep. 30 2024
1.59
1.61
Beat
Jun. 30 2024
1.49
1.62
Beat
Mar. 31 2024
0.94
1.45
Beat